Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181


Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.

Li J, Wang W, Xu SX, Magarvey NA, McCormick JK.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3360-5. doi: 10.1073/pnas.1017431108. Epub 2011 Jan 31.


Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri.

Laughton JM, Devillard E, Heinrichs DE, Reid G, McCormick JK.

Microbiology. 2006 Apr;152(Pt 4):1155-67.


The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.

Baroja ML, Herfst CA, Kasper KJ, Xu SX, Gillett DA, Li J, Reid G, McCormick JK.

J Bacteriol. 2016 Sep 9;198(19):2732-42. doi: 10.1128/JB.00425-16. Print 2016 Oct 1.


[Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].

Dickgiesser N, Brombacher A, Wiest W.

Geburtshilfe Frauenheilkd. 1987 Feb;47(2):104-6. German.


Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus.

Nagao M, Okamoto A, Yamada K, Hasegawa T, Hasegawa Y, Ohta M.

BMC Microbiol. 2009 Mar 10;9:52. doi: 10.1186/1471-2180-9-52.


Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus.

MDowell P, Affas Z, Reynolds C, Holden MT, Wood SJ, Saint S, Cockayne A, Hill PJ, Dodd CE, Bycroft BW, Chan WC, Williams P.

Mol Microbiol. 2001 Jul;41(2):503-12.


Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.

Dickgiesser N, Brombacher A.

Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jul;265(3-4):323-9.


Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.

Parsonnet J, Hansmann MA, Seymour JL, Delaney ML, Dubois AM, Modern PA, Jones MB, Wild JE, Onderdonk AB.

BMC Infect Dis. 2010 Aug 23;10:249. doi: 10.1186/1471-2334-10-249.


In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.

Laabei M, Young A, Jenkins TA.

Pediatr Infect Dis J. 2012 May;31(5):e73-7. doi: 10.1097/INF.0b013e3182493b21.


Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB.

J Clin Microbiol. 2005 Sep;43(9):4628-34.


Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus.

Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC.

Infect Immun. 2007 Sep;75(9):4519-27. Epub 2007 Jun 4.

Supplemental Content

Support Center